Over the past twenty-five years, Obesity rates have spiraled to the level nearly 5 hundred million individuals worldwide. The United States leads the world, with a startling 31 % of the population being termed obese.
It would take an army of accountants to forecast the medical and direct costs associated with obesity, but it is well documented that obesity is directly associated serious health issues such as heart attack, stroke, high blood pressure, and diabetes; making obesity one of the major factors that cause preventable death in U.S.
On the new product front, there is great news. Vivus Pharmaceuticals have recently announced a new weight loss pill, designated for considerable weight loss for obese patients. This groundbreaking medication is named Qsymia, a weight loss pill that was recently approved for prescription by the Food and drug administration.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
The results from the Food and Drug Administration's clinical trials are more than convincing. The weight loss pill outperformed any other drugs that were also tested by the FDA. In one independent study; patients taking it for one year lost 6.7 percent of their body weight. In another study patients lost a reported 8.9 percent. In that same study, patients on the strongest dosage lost 11 percent of total body weight. To put it in pounds, patients reported losing as many as 22 pounds.
The drugs that make the weight loss pill so effective are Phentermine, an appetite suppressant and Topiramate, an anti-consultant that causes a patient to feel more satisfied after a meal. It is probable that Qsymia is effective because of its two-pronged attack on overeating.
Research also reveals that Qsymia usage correlates to lower blood pressure and the easement of other cardiovascular risks associated with obesity. There is also reported improvement in the sleep disorder known as sleep apnea.
Qsymia has been approved for use, but not unrestricted use. Current guidelines suggest that the drug only be prescribed for patient with a BMI (Body mass index) greater than 30. In other words, the drug is for those clinically revealed as obese. In addition, Physicians and clinics that administer the drug are advised to closely monitor the patients. Side effects include congenital disorder in infants, if taken by women who are pregnant.
Qsymia is proving to be one of the best tools in the struggle to overcome obesity and get America healthy again. The foremost physicians and weight loss clinics have responded by offering Qsymia as an option for their patients. Equilibrium weight loss and longevity clinics offer Qsymia as part of a comprehensive line of weight loss programs.
It would take an army of accountants to forecast the medical and direct costs associated with obesity, but it is well documented that obesity is directly associated serious health issues such as heart attack, stroke, high blood pressure, and diabetes; making obesity one of the major factors that cause preventable death in U.S.
On the new product front, there is great news. Vivus Pharmaceuticals have recently announced a new weight loss pill, designated for considerable weight loss for obese patients. This groundbreaking medication is named Qsymia, a weight loss pill that was recently approved for prescription by the Food and drug administration.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
The results from the Food and Drug Administration's clinical trials are more than convincing. The weight loss pill outperformed any other drugs that were also tested by the FDA. In one independent study; patients taking it for one year lost 6.7 percent of their body weight. In another study patients lost a reported 8.9 percent. In that same study, patients on the strongest dosage lost 11 percent of total body weight. To put it in pounds, patients reported losing as many as 22 pounds.
The drugs that make the weight loss pill so effective are Phentermine, an appetite suppressant and Topiramate, an anti-consultant that causes a patient to feel more satisfied after a meal. It is probable that Qsymia is effective because of its two-pronged attack on overeating.
Research also reveals that Qsymia usage correlates to lower blood pressure and the easement of other cardiovascular risks associated with obesity. There is also reported improvement in the sleep disorder known as sleep apnea.
Qsymia has been approved for use, but not unrestricted use. Current guidelines suggest that the drug only be prescribed for patient with a BMI (Body mass index) greater than 30. In other words, the drug is for those clinically revealed as obese. In addition, Physicians and clinics that administer the drug are advised to closely monitor the patients. Side effects include congenital disorder in infants, if taken by women who are pregnant.
Qsymia is proving to be one of the best tools in the struggle to overcome obesity and get America healthy again. The foremost physicians and weight loss clinics have responded by offering Qsymia as an option for their patients. Equilibrium weight loss and longevity clinics offer Qsymia as part of a comprehensive line of weight loss programs.
About the Author:
Are you looking to find out if Qsymia Capsules are available around you? We all will have to get a prescription to get the Qsymia diet pills
Aucun commentaire:
Enregistrer un commentaire